Cytek Biosciences, Inc. CTKB Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s free cash flow margin?
- Cytek Biosciences, Inc. (CTKB) reported free cash flow margin of -6.2% in Q1 2026.
- How has Cytek Biosciences, Inc.'s free cash flow margin changed year-over-year?
- Cytek Biosciences, Inc.'s free cash flow margin decreased by 170.1% year-over-year, from 8.9% to -6.2%.
- What is the long-term trend for Cytek Biosciences, Inc.'s free cash flow margin?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s free cash flow margin has grown at a 113.9% compound annual growth rate (CAGR), from 0.2% to -4.4%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.